UBS Lux Equity Fund Biotech USD vs Allianz US High Yield AM
1. UBS Lux Equity Fund Biotech USD
2. Allianz US High Yield AM
Fund Holdings
We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.35) and Moderna (9.21). In comparison with Allianz US High Yield AM, we have 5 holdings where CCF Holdings is the largest holding (2.69), followed by CCO Holdings LLC (2.2) and Iron Mountain (2.05).
All Holdings
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Allianz US High Yield AM.
UBS Lux Equity Fund Biotech USD |
Allianz US High Yield AM |
1. Regeneron Pharmaceuticals Inc 10.04 % |
1. CCF Holdings LLC  2.69 % |
2. Vertex Pharmaceuticals Inc 9.35 % |
2. CCO Holdings LLC  2.2 % |
3. Moderna Inc 9.21 % |
3. Iron Mountain Inc  2.05 % |
4. Alnylam Pharmaceuticals Inc 6.96 % |
4. Caesars Entertainment Inc 1.53 % |
5. AbbVie Inc  5.53 % |
5. Bombardier Inc Pref 1.31 % |
6. Gilead Sciences Inc  4.66 % |
- |
7. Amgen Inc 4.3 % |
- |
8. BioNTech SE 4.13 % |
- |
9. Karuna Therapeutics Inc 3.75 % |
- |
10. Royalty Pharma Plc 3.37 % |
- |
The list of fund holdings was last updated on June 5, 2025.